Testing effectiveness (Phase 2)Study completedNCT00505895What this trial is testingFM 140 vs FM100 Study in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma M.D. Anderson Cancer Center 52
Early research (Phase 1)Active Not RecruitingNCT03459170What this trial is testingSafety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo TransplantWho this might be right forHematologic Malignancy Bellicum Pharmaceuticals 15
Testing effectiveness (Phase 2)Study completedNCT00002829What this trial is testingBone Marrow Transplantation in Treating Patients With LymphomaWho this might be right forLymphoma M.D. Anderson Cancer Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT07582172What this trial is testingTotal Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeWho this might be right forAcute Myeloid Leukemia With Complex KaryotypeMyelodysplastic Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+8 more City of Hope Medical Center
Early research (Phase 1)Study completedNCT00060372What this trial is testingIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT01203722What this trial is testingReduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic MalignanciesWho this might be right forHematologic Malignancies Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87
Not applicableLooking for participantsNCT06803745What this trial is testingStandard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)Who this might be right forAcute LeukemiaAcute Lymphoblastic Lymphoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 160
Testing effectiveness (Phase 2)UnknownNCT01844063What this trial is testingSafety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver FailureWho this might be right forLiver Failure Third Affiliated Hospital, Sun Yat-Sen University 210
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06607367What this trial is testingREscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2Who this might be right forPoor Graft FunctionAplastic Anemia Idiopathic Melbourne Health 20
Testing effectiveness (Phase 2)Looking for participantsNCT06918834What this trial is testingEfficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome PatientsWho this might be right forMyelodysplastic Syndromes Institute of Hematology & Blood Diseases Hospital, China 236
Not applicableEnded earlyNCT00957736What this trial is testingChronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forCancer Vanderbilt-Ingram Cancer Center 252
Testing effectiveness (Phase 2)UnknownNCT04313036What this trial is testing5-day Defibrotide Treatment for Hepatic SOS/VODWho this might be right forSinusoidal Obstruction SyndromeVeno-occlusive DiseaseBone Marrow Transplant Complications Loyola University 24
Testing effectiveness (Phase 2)Study completedNCT02626715What this trial is testingReduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDSWho this might be right forAcute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Hematopoietic Stem Cell Transplant (HSCT) Randy Windreich 21
Not applicableStudy completedNCT04188678What this trial is testingResiliency in Older Adults Undergoing Bone Marrow TransplantWho this might be right forLeukemiaLymphomaBlood Cancer+3 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 126
Post-approval studies (Phase 4)Study completedNCT00361140What this trial is testingBusulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)Who this might be right forMyelodysplastic SyndromesMyeloproliferative DisordersLeukemia, Lymphocytic+2 more H. Lee Moffitt Cancer Center and Research Institute 72
Testing effectiveness (Phase 2)Ended earlyNCT00499889What this trial is testingImatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML PatientsWho this might be right forLeukemia M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT00787761What this trial is testingEarly Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerWho this might be right forMyeloproliferative DisordersKidney CancerLeukemia+4 more Northside Hospital, Inc. 24
Testing effectiveness (Phase 2)UnknownNCT05066958What this trial is testingEx-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCTWho this might be right forAcute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Testing effectiveness (Phase 2)Ended earlyNCT01532635What this trial is testingA Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched RelativesWho this might be right forHematologic MalignancyLeukemiaAcute Lymphoblastic Leukemia+9 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4
Early research (Phase 1)Study completedNCT03932643What this trial is testingONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell TransplantWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes University of Nebraska 20